Clinical Applications for Biomarkers of Acute and Chronic Graft-versus-Host Disease

John E. Levine, Sophie Paczesny, Stefanie Sarantopoulos

Research output: Contribution to journalArticlepeer-review

49 Scopus citations


Acute and chronic graft-versus-host disease (aGVHD, cGVHD) are serious complications of allogeneic hematopoietic cell transplantation. The complex pathophysiology of these disease processes is associated with immune system activation, the release of cytokines and chemokines, and alterations in cell populations. The blood levels of specific protein and cellular levels in patients with GVHD have correlated with the development, diagnosis, and prognosis of GVHD. Here, we review the most promising biomarkers for aGVHD and cGVHD with clinical relevance. The utility of GVHD biomarkers in clinical care of allogeneic hematopoietic cell transplantation recipients needs to be proven through clinical trials, and potential approaches to trial design are discussed.

Original languageEnglish
Pages (from-to)S116-S124
JournalBiology of Blood and Marrow Transplantation
Issue number1 SUPPL.
StatePublished - Jan 2012
Externally publishedYes


  • Acute GVHD
  • Allogeneic hematopoietic cell transplantation
  • Biomarkers
  • Chronic GVHD


Dive into the research topics of 'Clinical Applications for Biomarkers of Acute and Chronic Graft-versus-Host Disease'. Together they form a unique fingerprint.

Cite this